NewTimeSpace News:On March 13, 2026, Q&M Dental Group, a mainboard-listed company on the Singapore Exchange, issued an announcement to reaffirm its regional expansion strategy. With a core focus on four major markets including Australia, Thailand, Singapore and China, the Group is scaling up its global dental service platform through proactive M&A activities coupled with disciplined organic growth.

The announcement indicated that Q&M Group’s expansion is backed by ample capital support. In August 2025, Q&M issued notes under its S$500 million Multicurrency Debt Issuance Programme, raising S$130 million in proceeds, which are mainly earmarked for organic expansion and potential M&A initiatives. Dr. Ng Chin Siau, Founder and Group Chief Executive Officer of Q&M, stated that the M&A pipeline in the Asia-Pacific region remains robust. Q&M is increasing its shareholdings through transaction structures such as long-term service agreements and the issuance of restricted shares, aligning interests with its partners and facilitating long-term value creation.

The announcement specified that Q&M’s expansion in various regions is progressing in an orderly manner: In Australia, the Group is conducting due diligence on an established dental clinic network with over 40 clinics and approximately 120 dentists. Its long-term goal is to expand the Australian clinic network to around 400 locations over the next five years through M&A, partnerships and organic growth.

In Thailand, the Group is focusing on the surging demand for aesthetic and high-end dental services, with relevant M&A opportunities entering the due diligence phase. As its core market, Singapore is seeing Q&M advance the proposed full acquisition of another well-known dental operator. The transaction includes a five-year profit guarantee of up to S$34 million and a 15-year service agreement with the sellers, with the long-term target to expand its local clinic network to about 300 locations within five years.

For the China market, Q&M is taking Aoxin Q&M Dental Group, its subsidiary, as the dedicated platform to consolidate all existing operations and future M&A projects in China. The Group plans to gradually increase its shareholding in Aoxin through various means and continue advancing M&A negotiations with several dental groups to accelerate scale expansion.

Q&M stated that with rigorous transaction selection, high-quality integration capabilities and ongoing due diligence across multiple markets, the Group is fully confident in achieving sustainable growth through strategic expansion.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.